MedPath

Medtronic HAMMOCK Post Approval Study

Completed
Conditions
Heart Valve Diseases
Registration Number
NCT03139721
Lead Sponsor
Medtronic Cardiac Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> 1. Subjects who require aortic or mitral valve replacement of their native valve.<br><br> 2. Subject is geographically stable and willing to return to the implanting site for<br> all follow-up visits.<br><br> 3. Subject is of legal age to provide informed consent in the country where they enroll<br> in the study.<br><br> 4. Subject has been adequately informed of risks and requirements of the study and is<br> willing and able to provide informed consent for participation in the clinical<br> study.<br><br>Exclusion Criteria:<br><br> 1. Subject requires concomitant replacement of the aortic and mitral valves.<br><br> 2. Subject requires a replacement of a previously implanted prosthetic aortic or mitral<br> valve.<br><br> 3. Subject requires a Bentall procedure for replacement of aortic valve or aortic root.

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Deaths, Reinterventions, or Explants;Number of Deaths, Reinterventions, or Explants
Secondary Outcome Measures
NameTimeMethod
Mean Gradient (mmHg);Peak Gradient (mmHg);Effective Orifice Area (EOA);Effective Orifice Area Index (EOAi);Cardiac Output;Cardiac Index;Performance Index;Transvalvular Regurgitation;Paravalvular Regurgitation;Total Regurgitation;New York Heart Association (NYHA) Classification;Mean Gradient;Peak Gradient;Effective Orifice Area (EOA);Effective Orifice Area Index (EOAi);Cardiac Output;Cardiac Index;Performance Index;Transvalvular Regurgitation;Paravalvular Regurgitation;Total Regurgitation;New York Heart Association (NYHA) Classification
© Copyright 2025. All Rights Reserved by MedPath